Fig. 2
From: Macitentan attenuates cardiovascular remodelling in infant rats with chronic lung disease
Alveolar count (A) and mean linear intercept (B) in N-P: normoxia (FiO20.21)-placebo (A n = 7, B n = 6); N-M: normoxia (FiO20.21)-macitentan (A n = 8, B n = 9); H-P: hyperoxia (FiO21.0)-placebo (A n = 7, B = 6); and H-M: hyperoxia (FiO21.0)-macitentan (A n = 7, B n = 7). Data are expressed as vertical box plots with median, 10th, 25th, 75th, and 90th percentiles. * displays significant difference to FiO20.21-placebo group, p < 0.05